These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 16110614)

  • 1. Angiogenesis pathway inhibitors.
    Herbst RS; LoRusso P; Isobe T; Hurwitz HI
    Cancer Chemother Biol Response Modif; 2005; 22():225-45. PubMed ID: 16110614
    [No Abstract]   [Full Text] [Related]  

  • 2. [Anti-angiogenic therapeutic strategies and inhibition of tumor growth].
    Bachelot T
    Ann Pathol; 1999; 19(5 Suppl):S74-5. PubMed ID: 10599459
    [No Abstract]   [Full Text] [Related]  

  • 3. Angiogenesis and current antiangiogenic strategies for the treatment of cancer.
    Oklu R; Walker TG; Wicky S; Hesketh R
    J Vasc Interv Radiol; 2010 Dec; 21(12):1791-805; quiz 1806. PubMed ID: 20980167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Targeting angiogenesis in oncology].
    Fayette J; Soria JC; Armand JP
    Pathol Biol (Paris); 2006 May; 54(4):199-205. PubMed ID: 16753494
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiogenesis inhibitors: from laboratory to clinical application.
    Nakamura T; Matsumoto K
    Biochem Biophys Res Commun; 2005 Jul; 333(2):289-91. PubMed ID: 15953588
    [No Abstract]   [Full Text] [Related]  

  • 6. Editorial: Angiogenesis agents.
    Marcinkiewicz C
    Curr Pharm Des; 2007; 13(35):3543-4. PubMed ID: 18220790
    [No Abstract]   [Full Text] [Related]  

  • 7. Can tumor angiogenesis be inhibited without resistance?
    Miller KD; Sweeney CJ; Sledge GW
    EXS; 2005; (94):95-112. PubMed ID: 15617473
    [No Abstract]   [Full Text] [Related]  

  • 8. [Bevacizumab].
    Taéron C
    Rev Infirm; 2009; (147):46-8. PubMed ID: 19317091
    [No Abstract]   [Full Text] [Related]  

  • 9. Angiogenesis inhibitors: what is the clinical future?
    Verheul HM; Pinedo HM
    Prog Drug Res; 2005; 63():67-91. PubMed ID: 16265877
    [No Abstract]   [Full Text] [Related]  

  • 10. The role of tumor oxygenation in vascular and clinical response to angiogenesis inhibition.
    Gee MS; Lee WM
    Adv Exp Med Biol; 2003; 510():1-5. PubMed ID: 12580396
    [No Abstract]   [Full Text] [Related]  

  • 11. Written in the blood.
    Lewis R
    Nature; 2006 Mar; 440(7084):710-1. PubMed ID: 16637100
    [No Abstract]   [Full Text] [Related]  

  • 12. [Anti-angiogenesis drugs as a potential approach in cancer therapy].
    Sela B
    Harefuah; 2000 Oct; 139(7-8):283-9. PubMed ID: 11062974
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical application of antiangiogenic therapy: microvessel density, what it does and doesn't tell us.
    Hlatky L; Hahnfeldt P; Folkman J
    J Natl Cancer Inst; 2002 Jun; 94(12):883-93. PubMed ID: 12072542
    [No Abstract]   [Full Text] [Related]  

  • 14. The chimeric human/mouse model of angiogenesis.
    Petitclerc E; von Schalscha T; Brooks PC
    Methods Mol Biol; 2000; 137():213-21. PubMed ID: 10948540
    [No Abstract]   [Full Text] [Related]  

  • 15. Targeted Therapies in Cancer - Fourth International Congress. Angiogenesis inhibition.
    Tawbi H; Agarwala SS
    IDrugs; 2005 Dec; 8(12):984-6. PubMed ID: 16320129
    [No Abstract]   [Full Text] [Related]  

  • 16. Angiogenesis in malignancy.
    Cao Y
    Semin Cancer Biol; 2009 Oct; 19(5):277-8. PubMed ID: 19945648
    [No Abstract]   [Full Text] [Related]  

  • 17. Angiogenesis and the progress of vascular and tumor biology: a tribute to Judah Folkman.
    Benedetta Donati M; Gozdzikiewicz J
    Thromb Haemost; 2008 Apr; 99(4):647-50. PubMed ID: 18392318
    [No Abstract]   [Full Text] [Related]  

  • 18. New therapeutic advances and perspectives in tumour angiogenesis.
    Pasquier E; André N
    Curr Cancer Drug Targets; 2010 Dec; 10(8):877-8. PubMed ID: 21288200
    [No Abstract]   [Full Text] [Related]  

  • 19. Aberrant tumor vasculature and angiogenesis: new opportunities for cancer therapy.
    Zhu Z
    Drug Discov Today; 2003 Sep; 8(18):827-8. PubMed ID: 12963316
    [No Abstract]   [Full Text] [Related]  

  • 20. Rationale, problems and perspectives in anti-angiogenic therapy.
    Lorusso G; Dell'Eva R; Vené R; Pfeffer U; Albini A
    Tumori; 2001; 87(6):S17-9. PubMed ID: 11989611
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.